Immunex submits sBLA for Enbrel

IMNX submitted an sBLA to the FDA for its Enbrel etanercept soluble TNF receptor to reduce the signs and symptoms of psoriatic arthritis as monotherapy or in combination with methotrexate. IMNX has re...